Systems, which drive convergence of dynamic proteomics and single cell biology for the first time, are creating this deeper connection to accelerate curative medicines.
Accelerate to discover
Related topics
Watch an exclusive webinar recording in collaboration with Accela exploring the Beacon platform and discover how cutting-edge single-cell technology is accelerating the discovery and development of novel therapeutics.
Presented by Tiago Santos, PhD, MBA, Market Development Executive, Bruker Cellular Analysis
Related technologies: Functional biology
Systems, which drive convergence of dynamic proteomics and single cell biology for the first time, are creating this deeper connection to accelerate curative medicines.
More info at:
https://brukercellularanalysis.com/